DUBR and glioma: Our results also highlighted that LINC00883 could serve as a potential prognostic biomarker and/or therapeutic target in glioma, which was further supported via the elucidation that inhibition of LINC00883 resulted in the suppression of tumorigenicity and multidrug resistance while inducing the apoptosis of glioma cells.